Examining concerns regarding FDA's proposed changes to generic drug labeling : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 1, 2014

• Pubblicazione: Washington : , : U.S. Government Publishing Office, , 2016
• Descrizione fisica: 1 online resource (v, 146 pages)
• Soggetto topico: Generic drugs - Labeling - United States; Drugs - Safety regulations - United States; Warning labels - Government policy - United States
• Soggetto genere / forma: Legislative hearings.
• Note generali: Title from title screen (viewed on Mar. 31, 2016).; Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.; "Serial No. 113-132."
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Examining concerns regarding FDA's proposed changes to generic drug labeling
• Titolo autorizzato: Examining concerns regarding FDA's proposed changes to generic drug labeling
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910707021503321
• Lo trovi qui: Univ. Federico II